GGrantIndex
← Leaderboards

Albert F Lobuglio

University Of Alabama At Birmingham

$1,259,317
Attributed
$1,259,317
Total exposure
8
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$20,605,796 · 9

By mechanism

P30$19,346,479 · 1
R01$842,641 · 1
P50$298,560 · 1
M01$118,116 · 6

Top collaborators

No co-investigators on record.

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject

Research focus

Human SubjectClinical ResearchHuman Therapy EvaluationMonoclonal AntibodyWomen'S HealthFemaleOvary NeoplasmsNeoplasm /Cancer Radionuclide TherapyDosagePharmacokineticsNeoplasm /Cancer ImmunotherapyRadionuclidesClinical Trial Phase IDisease /Disorder ModelLaboratory MouseInjection /InfusionPeritoneumNeoplasm /Cancer Radiation TherapyRadiosensitizerPaclitaxelNeoplasm /CancerBiomedical FacilityNeoplasm /Cancer Relapse /RecurrenceDrug Screening /Evaluation

Grant awards (24)

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$5,124,250
P30 · FY2003 · CA
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$4,789,670
P30 · FY2002 · CA
NOVEL RADIOIMMUNOTHERAPY FOR OVARIAN CANCER$336,365
R01 · FY2002 · CA
Targeted immunotherapy program$0
P50 · FY2002 · CA
Targeted immunotherapy program$0
P50 · FY2002 · CA
INTERFERON ENHANCED INTRAPERITONEAL RADIOIMMUNITY FOR OVARIAN CANCER$0
M01 · FY2002 · RR
Targeted immunotherapy program$0
P50 · FY2002 · CA
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$4,541,851
P30 · FY2001 · CA
NOVEL RADIOIMMUNOTHERAPY FOR OVARIAN CANCER$326,569
R01 · FY2001 · CA
INTERFERON ENHANCED INTRAPERITONEAL RADIOIMMUNITY FOR OVARIAN CANCER$0
M01 · FY2001 · RR
Targeted immunotherapy program$0
P50 · FY2001 · CA
Targeted immunotherapy program$0
P50 · FY2001 · CA
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$4,632,680
P30 · FY2000 · CA
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT$258,028
P30 · FY2000 · CA
NOVEL RADIOIMMUNOTHERAPY FOR OVARIAN CANCER$179,707
R01 · FY2000 · CA
Targeted immunotherapy program$99,520
P50 · FY2000 · CA
Targeted immunotherapy program$99,520
P50 · FY2000 · CA
Targeted immunotherapy program$99,520
P50 · FY2000 · CA
RECOMBINANT VACCINIA CEA (70DD) VACCINE IN LOW TUMOR BURDEN COLORECTAL CANCER$29,529
M01 · FY2000 · RR
IMAGING TRIAL OF 3622W94$29,529
M01 · FY2000 · RR
ONCO VAX CL IN COLORECTAL CANCER$29,529
M01 · FY2000 · RR
INTERFERON ENHANCED INTRAPERITONEAL RADIOIMMUNITY FOR OVARIAN CANCER$29,529
M01 · FY2000 · RR
IDEC-Y902B8 RADIOIMMUNOTHERAPY: RELAPSED B CELL LYMPHOMA$0
M01 · FY2000 · RR
RITUXAN IN TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA$0
M01 · FY2000 · RR